So, some quick hits.
There's a new study out from researchers at Oxford: Herd Immunity Threshold Against COVID-19 May Be Lower Than Believed.
According to an Oxford University study (pdf), the herd immunity threshold (HIT) may be lower than previous estimates because many people may already be innately immune to COVID-19—without ever having caught the disease.
The researchers suggest that many people may have already built up some degree of resistance to the virus from exposure to seasonal coronaviruses, such as the common cold.
“Given the mounting evidence that exposure to seasonal coronaviruses offers protection against clinical symptoms, it would be reasonable to assume that exposure to SARS-CoV-2 itself would confer a significant degree of clinical immunity,” the researchers suggest.
“Thus, a second peak may result in far fewer deaths, particularly among those with comorbidities in the younger age classes.”
All of which also suggests that people without comorbidities that are known to increase vulnerability or who are in frail health would probably be better off dispensing with masks, in order to get the benefit of a cold.
Nobody wants to tell you about this, because the MSM is locked into a second wave that can keep the country locked down--and especially the schools, now.
As if all that weren't bad enough, the MSM is having to work overtime to suppress the continued evidence that HCQ--when used early or even as a prophylactic treatment--is highly effective. Perhaps the most striking study is one out of India:
On July 9, 2020, Asia's biggest and densest slum shocked the world by announcing just one new positive COVID-19 case despite being a cluster and hotspot.
This remarkable success was widely reported, but the MSM uniformly and systematically eliminated any reference to HCQ--the "Trump drug":
Dharavi is no ordinary slum. It is one of the densest in the world, housing more than a million people. It provided some of the background for the Oscar-winning movie Slumdog Millionaire.
Dharavi contains pockets where as many as 650,000 people are crammed into 2.5 square kilometers. In comparison, New York City has only around 95,605 people for 2.5 square kilometers.
India feared the worst when a cluster outbreak of COVID-19 was reported in Dharavi. It could have become the biggest COVID-19 disaster zone in the world. But by using proactive measures, Dharavi contained the virus.
Media around the world, like the Los Angeles Times, have reported the success. Even the World Health Organization praised Dharavi.
Reports credit the huge turnaround to various factors. Most focused on Dharavi's use of widespread testing and contact tracing. One is the use of an anti-malarial drug. But they ignored the policy most responsible. Indian doctors used hydroxychloroquine (HCQ) for prophylaxis (preventive) treatment — the same drug the American media have politicized.
Dharavi's COVID-19 infection rate dropped drastically from April through June. In July, new infections were very low, almost reaching zero on July 9.
Officials have credited this turnaround to "[a] combination of hydroxychloroquine, vitamin D, and zinc tablets along with homeopathic medicines."
HCQ has been widely used across India to treat early-stage COVID-19. It is also prescribed for prophylaxis among those who have come into contact with people who have tested positive.
Few have heard of this from an epidemiology professor at Yale: Hydroxychloroquine Could Save 100,000 Lives If Widely Deployed:
Yale epidemiology professor Dr. Harvey Risch told Fox News's "Ingraham Angle" that he thinks hydroxychloroquine could save 75,000 to 100,000 lives if widely used to treat COVID-19, and that it's unfortunate that a "propaganda war" has been waged on the commonly prescribed drug which is not based on "medical facts."￼
"There are many doctors [from whom] I’ve gotten hostile remarks about saying that all the evidence is bad for it and, in fact, that is not true at all," Risch said on Monday, adding that he believes the drug should be used as a prophylactic for front-line healthcare workers, as has been done in India.
"All the evidence is actually good for it when it is used in outpatient uses." ... Risch added, arguing that the MSM refuses to cover the benefits of the drug, and is actively silencing those trying to address the efficacy of HCQ.
Imagine how many people have died thanks to the media's 'propaganda war.'
Note that well. The MSM isn't trying to cover both sides, according to this mainstream epidemiologist. This isn't about science news reporting. Instead, the MSM is waging a "propaganda war" and is "actively silencing" those who don't toe the Orange Man Bad line re HCQ.
Finally, here's a link that goes into more of the good news:
Fake news is keeping us away from the treatment to end the coronavirus
We've had political famines before, but is Covid the first political pandemic?
The media hostile to hydroxychloroquine successfully whipped up hysteria about its supposed dangers although it has an excellent safety record and it is not even alongside aspirin on the WHO list of the 100 most dangerous drugs. Specialists and doctors prescribing hydroxychloroquine for Rheumatoid Arthritis and Lupus have confirmed that thousands of patients are being prescribed the same dose Dr. Zelenko is giving for five days for years on end without problems.
Were the failed studies faulty because of ignorance or by design? Who gains from them? The drug companies can’t make much money on a generic drug, and they found in the media and the scientific community willing accomplices to stop its use. Gilead Sciences Inc. gives grants in addition to those mentioned above to Oxford University and the WHO. Is it possible that people in these prestigious institutions may have their integrity compromised by money, or is it mere coincidence that Gilead with their rival treatment is funding them?
Some of the media will do anything to make Trump look like a fool and these faulty trials were the perfect opportunity. The media hostile to hydroxychloroquine downplayed or cast doubt on the many successful studies and trials with hydroxychloroquine and made the most of the faulty trials as proof that the drug Trump had touted didn’t work.